Bexarotene prodrugs: Targeting through cleavage by NQO1 (DT-diaphorase)

被引：14
|
作者：
Schafer, Anja [1 ]
Burstein, Ethan S. [2 ]
Olsson, Roger [1 ,2 ,3 ]
机构：
[1] Univ Gothenburg, Dept Chem & Mol Biol Med Chem, SE-41296 Gothenburg, Sweden
[2] ACADIA Pharmaceut Inc, San Diego, CA 92121 USA
[3] Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2014年 / 24卷 / 08期
关键词：
Prodrugs; Parkinson's disease; Alzheimer's disease; dt diaphorase; Disease targeting; Bexarotene; INDOLEQUINONE ANTITUMOR AGENTS; NAD(P)H-QUINONE OXIDOREDUCTASE; QUINONE STRUCTURE; METABOLISM; ACTIVATION; DOPAMINE; EXPRESSION; MECHANISM; DESIGN; ELIMINATION;
D O I：
10.1016/j.bmcl.2014.03.003
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Bexarotene, a retinoid X receptor (RXR) agonist, is being tested as a potential disease modifying treatment for neurodegenerative conditions. To limit the peripheral exposure of bexarotene and release it only in the affected areas of the brain, we designed a prodrug strategy based on the enzyme NAD( P) H/quinone oxidoreductase (NQO1) that is elevated in neurodegenerative diseases. A series of indolequinones (known substrates of NQO1) was synthesized and coupled to bexarotene. Bexarotene-3(hydroxymethyl)-5-methoxy-1,2-dimethyl-1H-indole-4,7-dione ester 7a was cleaved best by NQO1. The prodrugs are not cleaved by esterase. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1944 / 1947
页数：4
相关论文
共 50 条
  • [21] Mitochondrial targeting of mouse NQO1 and CYP1B1 proteins
    Dong, Hongbin
    Shertzer, Howard G.
    Genter, Mary Beth
    Gonzalez, Frank J.
    Vasiliou, Vasilis
    Jefcoate, Colin
    Nebert, Daniel W.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 435 (04) : 727 - 732
  • [22] Transfection of COS-1 cells with DT-diaphorase cDNA: role of a base change at position 609
    V Misra
    HJ Klamut
    AM Rauth
    British Journal of Cancer, 1998, 77 : 1236 - 1240
  • [23] Targeting NQO1 as a Potential Anticancer Strategy Using the Small Molecule Deoxynyboquinone
    Parkinson, E. I.
    Bair, J. S.
    Bey, E. A.
    Boothman, D. A.
    Hergenrother, P. J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 154 - 154
  • [24] Targeting NAD(P)H:quinone oxidoreductase (NQO1) in pancreatic cancer
    Lewis, AM
    Ough, M
    Hinkhouse, MM
    Tsao, MS
    Oberley, LW
    Cullen, JJ
    MOLECULAR CARCINOGENESIS, 2005, 43 (04) : 215 - 224
  • [25] NAD(P)H-QUINONE OXIDOREDUCTASE(1) (DT-DIAPHORASE) - EXPRESSION, REGULATION, AND ROLE IN CANCER
    JOSEPH, P
    XIE, T
    XU, YH
    JAISWAL, AK
    ONCOLOGY RESEARCH, 1994, 6 (10-11) : 525 - 532
  • [26] Transfection of COS-1 cells with DT-diaphorase cDNA: role of a base change at position 609
    Misra, V
    Klamut, HJ
    Rauth, AM
    BRITISH JOURNAL OF CANCER, 1998, 77 (08) : 1236 - 1240
  • [27] AN ALTERNATIVELY SPLICED FORM OF NQO(1) (DT-DIAPHORASE) MESSENGER-RNA LACKING THE PUTATIVE QUINONE SUBSTRATE-BINDING SITE IS PRESENT IN HUMAN NORMAL AND TUMOR-TISSUES
    GASDASKA, PY
    FISHER, H
    POWIS, G
    CANCER RESEARCH, 1995, 55 (12) : 2542 - 2547
  • [28] NAD(P)H-QUINONE OXIDOREDUCTASE(1) (DT-DIAPHORASE) EXPRESSION IN NORMAL AND TUMOR-TISSUES
    BELINSKY, M
    JAISWAL, AK
    CANCER AND METASTASIS REVIEWS, 1993, 12 (02) : 103 - 117
  • [29] NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance
    Xiaoguang Li
    Zhida Liu
    Anli Zhang
    Chuanhui Han
    Aijun Shen
    Lingxiang Jiang
    David A. Boothman
    Jian Qiao
    Yang Wang
    Xiumei Huang
    Yang-Xin Fu
    Nature Communications, 10
  • [30] NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance
    Li, Xiaoguang
    Liu, Zhida
    Zhang, Anli
    Han, Chuanhui
    Shen, Aijun
    Jiang, Lingxiang
    Boothman, David A.
    Qiao, Jian
    Wang, Yang
    Huang, Xiumei
    Fu, Yang-Xin
    NATURE COMMUNICATIONS, 2019, 10 (1)
12345